Yubo International Biotech Limited (YBGJ)
OTCMKTS · Delayed Price · Currency is USD
0.0100
0.00 (0.00%)
Apr 21, 2026, 9:30 AM EST

YBGJ Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-1.08-1.78-1.2-1.2-1.54
Depreciation & Amortization
0.180.180.190.030.02
Asset Writedown & Restructuring Costs
----0.01
Other Operating Activities
-0.110.01---
Change in Accounts Receivable
0.03-0.09-0.030.11-0.16
Change in Inventory
0.010.180.11-0.16-0.1
Change in Accounts Payable
0.020.210.280.270.17
Change in Other Net Operating Assets
0.1-0.06-0.090.350.57
Operating Cash Flow
-0.84-1.34-0.74-0.6-1.02
Capital Expenditures
-----0.56
Sale of Property, Plant & Equipment
-0.12---
Sale (Purchase) of Intangibles
----0.04-
Investing Cash Flow
-0.12--0.04-0.56
Short-Term Debt Issued
0.851.030.750.67-
Total Debt Issued
0.851.030.750.67-
Net Debt Issued (Repaid)
0.851.030.750.67-
Issuance of Common Stock
----0.13
Other Financing Activities
-0.37---
Financing Cash Flow
0.851.410.750.670.13
Foreign Exchange Rate Adjustments
-0.01-0.19-0.02-0.040.1
Net Cash Flow
00-0.01-0.01-1.36
Free Cash Flow
-0.84-1.34-0.74-0.6-1.59
Free Cash Flow Margin
-6822.65%-38551.27%-122.21%-576.27%-127.42%
Free Cash Flow Per Share
-0.01-0.01-0.06-0.01-0.01
Levered Free Cash Flow
-0.73-2.670.45-0.37-0.95
Unlevered Free Cash Flow
-0.73-2.670.45-0.37-0.95
Change in Working Capital
0.170.250.270.580.49
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.